EP 3 402 440 B1 relates to a stent based device for treating an incompetent or regurgitant tricuspid (atrioventricular) valve.
Brief outline of the case
The OP maintained the patent according to AR3, as it considered, inter alia, a new MR (MRn) as lacking N over D3.
In the MRn,